BRAIN Biotechnology Research & Information Network AG (id:2832 BNN)
3.15 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/22/2024 7:08:02 PM)
Exchange closed, opens in 2 days 13 hours
About BRAIN Biotechnology Research & Information Network AG
Market Capitalization 63.79M
BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
| Headquarters (address) |
DarmstAedter Strasse 34-36 Zwingenberg 64673 Germany |
| Phone | 49 62 51 9331 0 |
| Website | https://www.brain-biotech.com |
| Employees | 319 |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Ticker | BNN |
| Exchange | Xetra Frankfurt Stock Exchange |
| Currency | EUR |
| 52 week range | 1.42 - 4.19 |
| Market Capitalization | 63.79M |
| P/E trailing | -8.29 |
| P/E forward | -15.26 |
| Price/Sale | 1.13 |
| Price/Book | 3.87 |
| Beta | 1.25 |
| EPS | -0.410 |
| EPS Germany (ID:66, base:321) | 2.35 |